"With over 30 years in the academic community, and service as a Professor of Biomedical Engineering and Orthopaedic Surgery, it has been an honor to build deep relationships and collaborations with some of the field's most recognizable investigators and thought-leaders. These Special Advisors help fortify the offerings we provide in the Group, and are available to assist with due diligence, strategic and technology assessments, protocol evaluation, and additional networking as necessary." - Scott Bruder, MD, PhD
Roy K. Aaron, MD
Orthopedic Surgery & Translational Research
Roy K. Aaron, MD, is a Professor of Orthopaedics and Professor of Molecular Pharmacology, Physiology, and Biotechnology at Brown University. He graduated from the Harvard Orthopedic Residency, completed a joint replacement fellowship at the Brigham and held two research fellowships at the National Institutes of Health. Dr. Aaron is currently the Director of the Orthopedic Clinical/Translational Research Program where he is focusing on clinical trial methodologies. In addition, he serves as the Research Director of the Miriam Hospital Joint Replacement Center. An active orthopedic surgeon, Dr. Aaron’s clinical research interests are centered on joint diseases and conservative therapies for joint preservation, including cartilage repair and other intra-articular tissue procedures. In the laboratory, Dr. Aaron has long been focused on the intersection of bone, cartilage and vascular biology, including novel approaches for tissue preservation, repair and regeneration. He is currently chair of the American Academy of Orthopedic Surgeons (AAOS) Basic Science Committee and is the editor of the AAOS Orthopedic Basic Science text, Volume 5. He has served on over 30 NIH Study Sections, federal inter-agency working groups and task forces, and committees of the Department of Defense, American Academy of Orthopedic Surgeons, and Orthopedic Research Society. Dr. Aaron is the recipient of numerous prizes and awards including a Lifetime Achievement Award from the New England Arthritis Foundation.
Arnold I. Caplan, PhD
Cell Therapy and Biologics
Arnold I. Caplan, PhD, is a Professor of Biology and Director of the Skeletal Research Center at Case Western Reserve University. He received his Ph.D. from The Johns Hopkins University School of Medicine. Dr. Caplan is a national and international scholar focusing on experimentation in the area of musculoskeletal and skin development. He has published over 400 papers and manuscripts and has long been supported by the NIH and other non-profit and for-profit agencies for his efforts in trying to understand the development, maturation, aging and repair of cartilage, bone, skin and other mesenchymal tissues and for his pioneering research on Mesenchymal Stem Cells. Dr. Caplan is the recipient of numerous prizes and awards including the Elizabeth Winston Lanier Award given by the American Academy of Orthopaedic Surgeons, the Marshall R. Urist Award for Excellence in Tissue Regeneration Research given by the Orthopaedic Research Society, the Genzyme Lifetime Achievement Award given by the International Cartilage Repair Society, the MSC Lifetime Achievement Award given by the National Center for Regenerative Medicine, and the Inaugural Termis Lifetime Achievement Award. He is one of the founders of Osiris Therapeutics, and has provided guidance to many industry firms around the world over the last 30 years.
Steven A. Goldstein, PhD
Biomedical Engineering and Orthopaedics
Steven Goldstein, PhD, is an Emeritus Professor of Orthopedic Surgery and Bioengineering at the University of Michigan, where he also earned his PhD. Dr. Goldstein's large and diverse research program included studies ranging from fracture repair and total joint replacement to investigating the mechanisms associated with inherited or degenerative connective tissue disorders and the development of strategies for tissue regeneration. He is widely recognized as a seminal leader in these fields, has published more than 200 peer reviewed papers and has received numerous awards for his investigations. A sample of these awards include the 1989 Kappa Delta Award for Excellence in Orthopaedic Research, which is the highest award given to orthopaedic investigators internationally. He also received the 2005 Lissner Medal for Career Achievements in Biomedical Engineering from the American Society of Mechanical Engineering and the 2003 Marshall Urist Award for Excellence in Tissue Regeneration Research from the Orthopaedic Research Society. As might be expected, he has been invited to give more than 150 lectures as a visiting professor, keynote or distinguished speaker at conferences, departments, and institutions throughout the country and throughout the world. Dr. Goldstein has also been very active in technology development (more than 25 patents and 2 spin-out companies) and has worked as a consultant, scientific board member or board member for numerous companies over the past 25 years. Importantly, in 2005 Dr. Goldstein was elected a member of the National Academy of Engineering.